Live Breaking News & Updates on Pulmonary Arterial

Stay updated with breaking news from Pulmonary arterial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Findings from STELLAR Phase III Trial Presented at ACC23 Report Novel First-in-class Medication Shows Promise in Treating Rare Heart Lung Condition

Significant improvements in six-minute walking distance were reported in the STELLAR Phase III Trial whose findings were unveiled during a Featured Clinical Research session on the final day of the March 4-6 American College of Cardiology Scientific Session, ACC23 Together with WCC. Researchers added a novel first-in-class medication in combination with background therapy in patients with pulmonary arterial hypertension (PAH), a severe, progressive condition that affects the heart and lungs. ....

United States , Mariusm Hoeper , Jane Leopold , American College Of Cardiology , Hannover Medical School In , Merck Co , Harvard Medical School Boston , Department Of Respiratory Medicine , Women Interventional Cardiology Health Initiative At Brigham , Acceleron Pharma Inc , American College , Background Therapy , Pulmonary Arterial , New England Journal , Deputy Director , Respiratory Medicine , Hannover Medical School , Merck Sharp , Landmark Trial , Interventional Cardiology Health Initiative , Harvard Medical School ,